Lamivudine Terminated Phase 3 Trials for severe or persistent diarrhea Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00650637A Study to Determine Effective Prophylaxis and Treatment of Nelfinavir-Associated Diarrhea